According to the Alzheimer’s Association 1 in 9 older Americans has Alzheimer’s disease or about roughly 4.7% of the US population. (ALZ.org) This number shows no sign of dwindling with an estimated increase to 13.8% by the year 2050. There’s is some good news though on the the treatment for Alzheimer’s disease. Recently, a US patent has been issued for BCM-95 Curcumin, a natural turmeric extract that has be in found in human clinical trials to be highly beneficial in preventing further cognitive decline and reducing amyloid beta plaques, one of the major causes of Alzheimer’s disease.
In the US patent (US Patent No. 8859020) BCM-95 Curcumin, the patented turmeric extract formulation from Arjuna Natural Extracts Ltd, it describes the unique combination of beneficial curcuminoids and turmeric essential oil in BCM-95, as well as its enhanced absorption and bioavailability. Having already undergone human clinical trials in patients with Alzheimer’s disease at Chinese University of Hong Kong under Professor Larry Baum (2008), BCM-95 Curcumin was found to not only be highly beneficial in preventing further cognitive decline and reducing amyloid beta plaques, but also increasing vitamin E levels in the body and enhancing curcumin levels in blood. Two other human clinical trials were also held in Australia under pioneering researcher Professor Ralph Martins.
‘These research findings will open a new world of hope to the millions battling Alzheimer’s every day, as they will now have a natural and safe alternative for addressing Alzheimer’s,’ says Dr. Benny Antony (Inventor of BCM-95), Joint Managing Director, Arjuna Natural Extracts Ltd.
Curcumin, the major component in turmeric, a spice widely used in India, may account for Alzheimer’s being less prevalent. People living in certain rural areas of India have less than 1% (0.84%) chance of developing the disease and in the larger cities and rural areas of India, the risk is just 2.4%. This compared to anywhere from 5% to 17% in the US depending where you live.
‘Studies have shown that Alzheimer’s is much less common in India than in the United States’, says board certified internist Jacob Teitelbaum, MD, author of Real Cause, Real Cure, ‘and a dietary factor may be making the difference. It’s turmeric, the spice that gives curry its yellow color. The active ingredient in turmeric is curcumin, and studies show that curcumin can dissolve the amyloid plaques that are a hallmark of Alzheimer’s.’
BCM-95 Curcumin is also being studied for various indications including inflammation, arthritis, diabetes, depression, cancer prevention and treatment, as an adjuvant to chemotherapy and cancer radiation, liver and gastrointestinal diseases and more. Currently it has 12 granted and 15 ongoing patents in India, US and Japan and more patents pending worldwide.
To learn more about Arjuna Natural Extracts Ltd visit their site at www.arjunanatural.com. To learn more about Alzheimer’s disease an…Alzheimer’s Association visit http://www.alz.org/. For more information on Curcumin and Alzheimer’s disease click here.